Literature DB >> 19059800

Pro-inflammatory effect of leptin on peripheral blood mononuclear cells of patients with ankylosing spondylitis.

Min-Chan Park1, Soo-Jin Chung, Yong-Beom Park, Soo-Kon Lee.   

Abstract

OBJECTIVES: This study was performed to investigate whether leptin mRNA expression is increased from peripheral blood mononuclear cells (PBMCs) of patients with active ankylosing spondylitis (AS) and whether it stimulates the production of pro-inflammatory cytokines.
METHODS: Twenty patients with active AS were enrolled and their Bath AS disease activity index (BASDAI) and levels of acute phase reactants were measured. Leptin, interleukin (IL)-6, and tumor necrosis factor (TNF)-alpha mRNA expressions and their protein productions were determined in PBMCs of patients with AS using semi-quantitative reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay. Then, the results were compared with those from 20 healthy controls, as were clinical and laboratory parameters reflecting disease activity. The changes of pro-inflammatory cytokine productions from PBMCs in response to leptin stimulation were also determined.
RESULTS: Leptin, IL-6 and TNF-alpha mRNA expressions of PMBCs from patients with AS were significantly higher than controls. Similar significances were also found in the measurements for leptin and cytokine levels of supernatants, and leptin levels correlated well with IL-6 expression (r=0.871, p<0.001) and BASDAI (r=0.691, p<0.001) in patients with AS. Stimulation of PBMCs by exogenous leptin significantly increased the production of IL-6 and TNF-alpha in PBMCs from patients with AS in a dose-dependent fashion and these increases were much exacerbated compared to controls.
CONCLUSION: Our results shows that leptin production is increased and its stimulation of PBMCs significantly increased the production of pro-inflammatory cytokines in patients with active AS, suggesting its pro-inflammatory effect in pathogenesis of AS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059800     DOI: 10.1016/j.jbspin.2008.04.018

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  15 in total

1.  Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis.

Authors:  Ki-Jo Kim; Ji-Young Kim; Su-Jung Park; Hosung Yoon; Chong-Hyeon Yoon; Wan-Uk Kim; Chul-Soo Cho
Journal:  Clin Rheumatol       Date:  2012-05-30       Impact factor: 2.980

2.  Role of leptin in autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Siloşi; Suzana Rogoz
Journal:  Maedica (Bucur)       Date:  2013-03

Review 3.  Roles of leptin in bone metabolism and bone diseases.

Authors:  Xu Xu Chen; Tianfu Yang
Journal:  J Bone Miner Metab       Date:  2015-03-18       Impact factor: 2.626

4.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

Review 5.  Leptin in immuno-rheumatological diseases.

Authors:  Marta Vadacca; Domenico P E Margiotta; Luca Navarini; Antonella Afeltra
Journal:  Cell Mol Immunol       Date:  2011-03-14       Impact factor: 11.530

Review 6.  Role of leptin in the activation of immune cells.

Authors:  Patricia Fernández-Riejos; Souad Najib; Jose Santos-Alvarez; Consuelo Martín-Romero; Antonio Pérez-Pérez; Carmen González-Yanes; Víctor Sánchez-Margalet
Journal:  Mediators Inflamm       Date:  2010-03-23       Impact factor: 4.711

7.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

8.  Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases.

Authors:  Liberato Giardullo; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Natalia Mansueto; Francesco Paolo Cantatore
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

9.  Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.

Authors:  Carrie Wagner; Sudha Visvanathan; Jürgen Braun; Désirée van der Heijde; Atul Deodhar; Benjamin Hsu; Michael Mack; Michael Elashoff; Robert D Inman
Journal:  Ann Rheum Dis       Date:  2011-10-28       Impact factor: 19.103

Review 10.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.